Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
GILD
GILD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GILD News
WHO Launches Clinical Trial for Ebola Treatments
1d ago
seekingalpha
Key Wall Street Rating Updates on Monday
2d ago
CNBC
Gilead's Trodelvy Receives FDA Approval for Expanded Use
Jun 27 2026
Yahoo Finance
Biotech Sector Update: FDA and EU Approvals
Jun 26 2026
NASDAQ.COM
FDA Approves Trodelvy for First-Line Treatment of Metastatic TNBC
Jun 25 2026
NASDAQ.COM
QQQ ETF Outperforms S&P 500 Over Last Decade
Jun 25 2026
Fool
FDA Approves Trodelvy for First-Line Treatment of Triple-Negative Breast Cancer
Jun 25 2026
NASDAQ.COM
QQQ ETF Outperforms S&P 500 with Strong Tech Growth
Jun 25 2026
NASDAQ.COM
Gilead's Trodelvy Approved by FDA for Triple-Negative Breast Cancer
Jun 24 2026
seekingalpha
Trodelvy Approved by FDA for First-Line mTNBC Treatment
Jun 24 2026
Newsfilter
Oncology Research Sees New Opportunities with DDR Inhibitors
Jun 24 2026
Globenewswire
Oncology Research Sees New Opportunities with DDR Inhibitors
Jun 24 2026
Newsfilter
U.S. Supports Clinical Trials for Ebola Antibody Drug in Congo
Jun 23 2026
Newsfilter
U.S. Launches Investigation into Germany's Pharma Policies
Jun 19 2026
CNBC
Gilead's HIV Prevention Drug Filing Accepted by FDA
Jun 17 2026
NASDAQ.COM
Rackspace Partners with AMD for 30MW Computing Capacity Deployment
Jun 16 2026
CNBC
Show More News
